Ionis Pharmaceuticals, Inc.
IONS
$81.84
$0.530.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -204.09% | 184.08% | -40.81% | 25.72% | -112.00% |
| Total Depreciation and Amortization | -17.46% | 1.06% | 2.47% | -4.11% | -1.54% |
| Total Amortization of Deferred Charges | 0.36% | 0.24% | -1.91% | -0.24% | 0.42% |
| Total Other Non-Cash Items | -107.26% | 62.28% | -28.97% | 59.29% | -19.25% |
| Change in Net Operating Assets | 81.00% | 30.82% | 32.92% | -625.68% | 91.00% |
| Cash from Operations | -186.85% | 200.37% | -29.82% | -1.00% | 4.08% |
| Capital Expenditure | 57.17% | 2.16% | 50.67% | -181.55% | -45.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 189.65% | -158.88% | 95.32% | 128.25% | -582.99% |
| Cash from Investing | 176.07% | -170.44% | 149.89% | 120.02% | -645.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50% | 4.76% | 99.91% | -92,702.08% | -23.08% |
| Issuance of Common Stock | 6,213.83% | -42.57% | 422.38% | -99.91% | 19,009.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,413.07% | -43.29% | 104.98% | -108.89% | 19,299.57% |
| Foreign Exchange rate Adjustments | -113.78% | 156.47% | 147.74% | -238.86% | 1,621.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.93% | 49.73% | 123.90% | -327.83% | 173.98% |